Sector Gamma AS’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.9M Buy
43,962
+11,416
+35% +$3.75M 3.04% 11
2025
Q4
$11.4M Buy
32,546
+22,943
+239% +$7.75M 2.6% 17
2025
Q3
$3.1M Sell
9,603
-9,176
-49% -$2.85M 0.77% 38
2025
Q2
$7.3M Sell
18,779
-10,000
-35% -$4.02M 2.39% 17
2025
Q1
$12.5M Buy
28,779
+11,500
+67% +$4.62M 4.01% 10
2024
Q4
$6.37M Sell
17,279
-9,000
-34% -$3.77M 2.19% 18
2024
Q3
$13.7M Buy
26,279
+2,000
+8% +$1.07M 4.15% 9
2024
Q2
$13.2M Sell
24,279
-10,018
-29% -$5.3M 4.91% 5
2024
Q1
$17.8M Buy
34,297
+6,490
+23% +$3.23M 5.01% 7
2023
Q4
$13.1M Sell
27,807
-13,340
-32% -$6.17M 3.18% 14
2023
Q3
$17.9M Buy
41,147
+9,796
+31% +$4.44M 4.58% 8
2023
Q2
$13.9M Sell
31,351
-4,428
-12% -$2.04M 3.12% 14
2023
Q1
$16.5M Sell
35,779
-11,998
-25% -$5.71M 3.99% 9
2022
Q4
$24.5M Buy
47,777
+1,745
+4% +$886K 5.6% 5
2022
Q3
$20.9M Buy
46,032
+11,732
+34% +$5.61M 5.39% 8
2022
Q2
$16.6M Buy
34,300
+5,282
+18% +$2.61M 3.7% 10
2022
Q1
$14.3M Sell
29,018
-5,384
-16% -$2.46M 3.1% 13
2021
Q4
$15.9M Sell
34,402
-8,790
-20% -$3.7M 3.75% 12
2021
Q3
$16.1M Sell
43,192
-1,432
-3% -$544K 3.21% 16
2021
Q2
$17M Sell
44,624
-12,147
-21% -$4.64M 3.02% 13
2021
Q1
$20.4M Buy
56,771
+9,411
+20% +$3.03M 3.73% 11
2020
Q4
$15.2M Sell
47,360
-20,442
-30% -$6.27M 2.89% 17
2020
Q3
$18.2M Sell
67,802
-1,200
-2% -$323K 4.14% 11
2020
Q2
$18.1M Sell
69,002
-20,600
-23% -$5.5M 3.75% 11
2020
Q1
$20.3M Buy
89,602
+13,094
+17% +$3.57M 4.34% 8
2019
Q4
$23.1M Buy
76,508
+1,901
+3% +$523K 3.7% 11
2019
Q3
$17.9M Buy
74,607
+1,500
+2% +$411K 3.03% 11
2019
Q2
$20.6M Buy
73,107
+34,094
+87% +$9.31M 3.32% 12
2019
Q1
$11.2M Sell
39,013
-34,500
-47% -$9.98M 1.8% 18
2018
Q4
$19.3M Sell
73,513
-10,000
-12% -$2.75M 3.25% 14
2018
Q3
$22.9M Sell
83,513
-4,397
-5% -$1.14M 3.59% 11
2018
Q2
$20.9M Buy
87,910
+2,000
+2% +$463K 3.48% 11
2018
Q1
$18.9M Sell
85,910
-35,400
-29% -$8.32M 3.4% 13
2017
Q4
$27.3M Sell
121,310
-61,300
-34% -$13.1M 4.59% 7
2017
Q3
$34.7M Buy
182,610
+3,200
+2% +$609K 5.29% 6
2017
Q2
$33.8M Sell
179,410
-25,200
-12% -$4.53M 4.91% 10
2017
Q1
$33.8M Buy
204,610
+63,800
+45% +$10.1M 5.38% 7
2016
Q4
$20.2M Buy
140,810
+17,960
+15% +$2.4M 3.81% 14
2016
Q3
$15.2M Buy
122,850
+18,550
+18% +$2.4M 2.66% 18
2016
Q2
$13.7M Buy
+104,300
New +$14.3M 2.6% 20

Other funds holding ELV

Sector Gamma AS's ELV Position: Q1 2026 in Review

Sector Gamma AS increased its Elevance Health (ELV) stake by 35% in Q1 2026, buying an estimated $3.75M and bringing the position to 43,962 shares worth $12.9M. The position accounts for 3.04% of the portfolio, ranked #11.

Sector Gamma AS first reported a position in ELV in Q2 2016 and has held it in 40 quarters since. The position peaked at $34.7M in Q3 2017. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Sector Gamma AS held 43,962 shares of Elevance Health worth $12.9M as of Q1 2026.
  • Sector Gamma AS bought 11,416 Elevance Health shares in Q1 2026, an estimated $3.75M.
  • Elevance Health made up 3.04% of Sector Gamma AS's portfolio in Q1 2026, its #11 holding.
  • Sector Gamma AS first reported a position in Elevance Health in Q2 2016 and has held it in 40 quarters since.
  • Sector Gamma AS's Elevance Health position peaked at $34.7M in Q3 2017.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Sector Gamma AS's 13F filing for Q1 2026, filed 7 May 2026.